Search Medical Condition
Please enter condition
Please choose location

Lambeth, United Kingdom Clinical Trials

A listing of Lambeth, United Kingdom clinical trials actively recruiting patients volunteers.

RESULTS

Found (460) clinical trials

A Study of Durvalumab (MEDI4736) and IPH2201 in Solid Tumors

This is a Phase 1, multicenter, open-label, single-arm dose-escalation and dose-expansion study of durvalumab in combination with IPH2201 to evaluate the safety, tolerability, PK, immunogenicity, pharmacodynamics, and antitumor activity in adult subjects with selected advanced solid tumors. The study consists of 2 parts: dose escalation and dose expansion. Subjects will ...

Phase

0.73 miles

Learn More »

A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache

This study is a multi-center, triple-blinded, placebo-controlled, randomized clinical trial for adjunctive prophylactic treatment of episodic migraine headache (with or without aura) using neuromodulation device developed by Scion NeuroStim, LLC (SNS). The investigational use of the device for episodic migraine headache has been reviewed by the FDA and is classified ...

Phase N/A

1.38 miles

Learn More »

Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

330 Patients who have completed at least one year of treatment with aflibercept will be randomized to two different aflibercept regimens and followed for 76 weeks.

Phase

1.53 miles

Learn More »

An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation

Acute myeloid leukaemia (AML) is a form of cancer that is common in older patients. Mutations in the isocitrate dehydrogenase enzyme 2 (IDH2) have been found in approximately 15% of patients with AML. The outcome of first line chemotherapy treatment is poor and many patients fail to attain complete remission ...

Phase

1.53 miles

Learn More »

Safety and Efficacy Study of SOM230 s.c. in Cluster Headache

The purpose of this non-confirmatory study is to determine if SOM230 has adequate efficacy and safety to warrant further clinical development in cluster headache (CH). This study will be a sequential design of SOM230 vs. Placebo.

Phase

1.53 miles

Learn More »